Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000921895-19-000831
Filing Date
2019-03-19
Accepted
2019-03-19 19:02:19
Documents
1
Period of Report
2018-08-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form3a11577002_03192019.html 3/A  
1 OWNERSHIP DOCUMENT form3a11577002_03192019.xml 3/A 2567
  Complete submission text file 0000921895-19-000831.txt   4188
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Issuer) CIK: 0001497504 (see all company filings)

EIN.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PLX PHARMA,INC.8285 EL RIO STREET SUITE 210 HOUSTON TX 77054
Business Address
Deliargyris Efthymios (Reporting) CIK: 0001751617 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-36351 | Film No.: 19693163